PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.39%
Negative revenue growth while FSLR stands at 29.91%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-28.35%
Negative gross profit growth while FSLR is at 45.14%. Joel Greenblatt would examine cost competitiveness or demand decline.
-194.50%
Negative EBIT growth while FSLR is at 59.48%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-360.84%
Negative operating income growth while FSLR is at 63.44%. Joel Greenblatt would press for urgent turnaround measures.
-375.90%
Negative net income growth while FSLR stands at 63.16%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-380.00%
Negative EPS growth while FSLR is at 62.76%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-18766.67%
Negative diluted EPS growth while FSLR is at 63.08%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.90%
Share change of 0.90% while FSLR is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-50.22%
Reduced diluted shares while FSLR is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-68.37%
Negative OCF growth while FSLR is at 124.60%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-68.37%
Negative FCF growth while FSLR is at 82.98%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-70.54%
Negative 10Y revenue/share CAGR while FSLR stands at 15.26%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-59.76%
Negative 5Y CAGR while FSLR stands at 68.88%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-65.22%
Negative 3Y CAGR while FSLR stands at 75.81%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
96.53%
10Y OCF/share CAGR under 50% of FSLR's 923.38%. Michael Burry would worry about a persistent underperformance in cash creation.
-145.05%
Negative 5Y OCF/share CAGR while FSLR is at 0.09%. Joel Greenblatt would question the firm’s operational model or cost structure.
82.95%
3Y OCF/share CAGR 1.25-1.5x FSLR's 69.09%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
-672.69%
Negative 10Y net income/share CAGR while FSLR is at 240.63%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-343.37%
Negative 5Y net income/share CAGR while FSLR is 815.86%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
23.54%
Below 50% of FSLR's 509.55%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-111.62%
Negative equity/share CAGR over 10 years while FSLR stands at 59.59%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-812.15%
Negative 5Y equity/share growth while FSLR is at 61.68%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-155.81%
Negative 3Y equity/share growth while FSLR is at 44.23%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
36.46%
AR growth well above FSLR's 18.46%. Michael Burry fears inflated revenue or higher default risk in the near future.
-52.87%
Inventory is declining while FSLR stands at 34.12%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
10.37%
Asset growth above 1.5x FSLR's 6.12%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-19.39%
We have a declining book value while FSLR shows 4.38%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
11.00%
Debt shrinking faster vs. FSLR's 69.27%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-19.49%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.